Journal of Clinical Endocrinology & Metabolism, Vol 76, 103-107, Copyright © 1993 by Endocrine Society

ARTICLES

Effects of calcium restriction on metabolic characteristics of premenopausal women

MJ Barger-Lux and RP Heaney
Creighton University School of Medicine, Department of Internal Medicine, Omaha, Nebraska 68131.

We studied 28 healthy premenopausal women before and after manipulating Ca intake, and then in response to a hypercalcemic challenge. Women with low Ca intakes at entry (< 17.5 mmol/day) were restricted to about 5 mmol/day (low-Ca), and those with higher self-selected intakes were supplemented to about 70 mmol/d (high-Ca). After 8 weeks on these regimens, more bone resorption was occurring among the low-Ca women, as evidenced by their higher values for immunoreactive PTH and urine hydroxyproline. There was a 7-fold range in 24-h urine Ca among the low- Ca women, with upper values equivalent to about 80% of intake. In response to induced hypercalcemia (0.5 mmol Ca/kg lean body mass, infused over 4 h), the low-Ca group had greater increases in serum Ca (1.31 vs. 1.05 mmol/L, P < 0.05) and reached a marginally higher peak (3.64 vs. 3.50 mmol/L, P < 0.1). Despite these greater calcemic responses, the low-Ca women excreted a smaller fraction of the infused Ca (44.3 vs. 62.2%, P < 0.02). Furthermore, preinfusion urine Ca was directly correlated with excretion of infused Ca in the low-Ca women, but not in the high-Ca women. Preinfusion differences between groups in immunoreactive PTH and urine hydroxyproline tended to reappear within 2 days. Our findings show that there are detectable differences in the Ca regulatory system between subjects at practical extremes of Ca intake, and that these differences persist through exposure to a temporary Ca surfeit. Ca-restricted women have higher levels of PTH and of bone remodeling activity. There is considerable variation in the apparent capacity to conserve Ca among women with low intakes. None of our subjects had high-P diets. Thus, our findings show that Ca restriction can evoke a persistent PTH response in the absence of a high P intake.

This article has been cited by other articles:

				R. P. Heaney Dairy and Bone Health J. Am. Coll. Nutr., February 1, 2009; 28(Supplement_1): 82S - 90S. [Abstract] [Full Text] [PDF]

				R. P. Heaney Phosphorus Nutrition and the Treatment of Osteoporosis Mayo Clin. Proc., January 1, 2004; 79(1): 91 - 97. [Abstract] [PDF]

				J. J.B. Anderson and S. C. Garner Controversy over Dietary Phosphorus J. Am. Coll. Nutr., August 1, 2001; 20(4): 269 - 270. [Full Text] [PDF]

				L. Sax The Institute of Medicine's "Dietary Reference Intake" for Phosphorus: A Critical Perspective J. Am. Coll. Nutr., August 1, 2001; 20(4): 271 - 278. [Abstract] [Full Text] [PDF]

				K. Åkesson, K.-H. W. Lau, P. Johnston, E. Imperio, and D. J. Baylink Effects of Short-Term Calcium Depletion and Repletion on Biochemical Markers of Bone Turnover in Young Adult Women J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1921 - 1927. [Abstract] [Full Text]

				M. Sanchez, A. de la Sierra, A. Coca, E. Poch, V. Giner, and A. Urbano-Marquez Oral Calcium Supplementation Reduces Intraplatelet Free Calcium Concentration and Insulin Resistance in Essential Hypertensive Patients Hypertension, January 1, 1997; 29(1): 531 - 536. [Abstract] [Full Text] [PDF]

				B. L. Chapin, H. J. LeMar Jr, D. H. Knodel, and P. L. Carter Secondary Hyperparathyroidism Following Biliopancreatic Diversion Arch Surg, October 1, 1996; 131(10): 1048 - 1052. [Abstract] [PDF]